|
Market Closed -
Toronto S.E.
20:08:50 15/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.110 CAD | -3.75% |
|
+37.92% | +260.53% |
| 09-29 | Medicure Inc. Completes Enrollment In Its MEND-PNPO Phase 3 Clinical Trial | CI |
| 09-09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
| Market Cap | 42.89M 30.21M 26.97M 25.06M 22.8M 2.86B 43.67M 301M 118M 1.49B 113M 111M 4.78B | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 39.95M 28.14M 25.12M 23.34M 21.23M 2.67B 40.67M 280M 110M 1.39B 106M 103M 4.45B | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
72.7% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MPH | Delayed | |
OTC Markets
| MCUJF | Delayed | |
|
Deutsche Boerse AG
| NGQ1 | Delayed | |
|
Börse Stuttgart
| NGQ1 | Delayed | |
|
Boerse Muenchen
| NGQ1 | Real-time |
Last Transcript: Medicure Inc.
| 1 day | -3.75% | ||
| 1 week | +37.92% | ||
| Current month | +44.72% | ||
| 1 month | +63.75% | ||
| 3 months | +284.11% | ||
| 6 months | +204.44% | ||
| Current year | +260.53% |
| 1 week | 2.98 |  | 4.95 |
| 1 month | 2.6 | | 4.95 |
| Current year | 0.85 | | 4.95 |
| 1 year | 0.85 | | 4.95 |
| 3 years | 0.63 | | 4.95 |
| 5 years | 0.63 | | 4.95 |
| 10 years | 0 | | 10.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 15/09/1997 |
James Kinley
DFI | Director of Finance/CFO | 48 | 15/07/2011 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 15/09/1997 |
Arnold Naimark
BRD | Director/Board Member | 93 | 28/02/2000 |
Brent Fawkes
BRD | Director/Board Member | 56 | 22/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/30/26 A | Option | Chief Technology Officer | -20,000 | 0.1916% | ||
| 3/28/25 A | Option | Chief Technology Officer | 7,500 | 0.0719% | ||
| 3/28/25 A | Option | Director | 7,200 | 0.0690% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.75% | +37.92% | +273.64% | +156.88% | 31.21M | |
| +0.21% | -4.63% | +55.34% | +71.32% | 68.92B | |
| +1.66% | +7.51% | +8.12% | +60.04% | 51.9B | |
| +3.14% | +7.17% | +12.48% | +44.42% | 48.73B | |
| +3.45% | +4.70% | +33.44% | +35.96% | 43.13B | |
| -2.20% | +0.61% | +281.88% | +532.76% | 41.48B | |
| +6.43% | +6.84% | +18.32% | +109.23% | 39.96B | |
| +1.28% | +1.39% | +11.69% | +45.10% | 30.6B | |
| +2.10% | -7.78% | +35.46% | +1.35% | 26.01B | |
| +1.74% | -2.02% | -13.55% | -12.92% | 22.27B | |
| Average | +1.41% | -0.85% | +71.68% | +104.41% | 37.3B | |
| Weighted average by Cap. | +1.88% | -0.25% | +52.80% | +105.47% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 21.91M 15.43M 13.77M 12.8M 11.64M 1.46B 22.3M 154M 60.16M 763M 57.91M 56.68M 2.44B | 28.86M 20.32M 18.14M 16.86M 15.34M 1.93B 29.38M 203M 79.25M 1B 76.27M 74.66M 3.21B |
| Net income | -1.04M -732K -653K -607K -552K -69.32M -1.06M -7.29M -2.85M -36.17M -2.75M -2.69M -116M | -7.1M -5M -4.46M -4.15M -3.77M -473M -7.22M -49.82M -19.49M -247M -18.76M -18.36M -790M |
| Net Debt | -6.32M -4.45M -3.97M -3.69M -3.36M -421M -6.43M -44.34M -17.35M -220M -16.7M -16.34M -704M | -2.94M -2.07M -1.85M -1.72M -1.56M -196M -3M -20.66M -8.09M -102M -7.78M -7.62M -328M |
Employees
38
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | CA$4.110 | -3.75% | 4,510 |
| 14/10/26 | CA$4.270 | +15.41% | 5,112 |
| 13/10/26 | CA$3.700 | +24.16% | 11,192 |
| 09/10/26 | CA$2.980 | 0.00% | 1,502 |
- Stock Market
- Stocks
- MPH Stock
Select your edition
All financial news and data tailored to specific country editions
